Mar 11, 2015
'Research and innovation in interest of the patient'

One of the main tasks of the public health corporations in Norway is research, and as an integral part of the clinical everyday life, they contribute to high quality healthcare.

A national report from the specialist healthcare in 2014 has been published (only in Norwegian), and the stories included are selected to show the scientific breadth and geographical spread in the research.

One of the stories is about Lytix Biopharma.

See the complete report (about Lytix Biopharma on pages 10-11), only in Norwegian.

See the Lytix Biopharma story (only in Norwegian) posted on